This result is consistent with increased production of ROS by other HDAC inhibitors in solid tumors5 and in HL-60 leukemia cells.4 Such changes in the cellular redox status also compromise the integrity of the mitochondrial membrane. The gene discussed is HDAC9; the disease is Hodgkins lymphoma.